Clinical studies have shown that treatment with thymosin alpha 1 increases response to vaccination.
Stefan Gravenstein
Advertisement
Stefan Gravenstein is professor of medicine, Brown University and clinical director, quality improvement, at Quality Partners
Articles by Stefan Gravenstein
Advertisement
Latest Updated Articles
Influenza Vaccine Enhancement with Immunomodulating Peptide Thymosin Alpha 1Published: January 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Trends in Formulation eBook October 2025
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
Analytics, Automation, and Quality Driving the Next Era of Drug Development
4
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
5
